[Long acting analogue of somatostatin (Octreotide) for treatment of patients with neurochorioretinitis due to ocular sarcoidosis who failed corticosteroids therapy].
Neurochorioretinitis due to the course of ocular sarcoidosis is relatively rare case. It usually responds well to conventional treatment with corticosteroids. We want to present the patient effectively treated with long acting analogue of somatostatin (Octreotide), who failed to respond to previous corticosteroids treatment.
Jurowski
Piotr
P
Kliniki Okulistycznej Instytutu Chirurgii Wojskowej Akademii Medycznej w Łodzi.
Goś
Roman
R
Kunert-Radek
Jolanta
J
D002825:Chorioretinitis / Q000188:drug therapy* / Q000209:etiology*; D005128:Eye Diseases / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006728:Hormones / Q000008:administration & dosage; D006801:Humans; D008875:Middle Aged; D015282:Octreotide / Q000008:administration & dosage*; D009882:Ophthalmic Nerve / Q000187:drug effects; D012507:Sarcoidosis / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D013997:Time Factors; D016896:Treatment Outcome
D005938:Glucocorticoids; D006728:Hormones; D015282:Octreotide